Literature DB >> 22435247

The relative false negative rate of isosulfan blue in detecting sentinel lymph nodes in early breast cancer.

Nawin Kantaraksa1, Youwanush Kongdan, Ronnarat Suvikapakornkul, Yodying Wasutit, Prakasit Chirappapha, Panuwat Lertsithichai.   

Abstract

OBJECTIVE: To determine the false negative rate of the isosulfan blue injection method of SLN detection in early breast cancer, relative to that of the combined blue dye and radiocolloid injection method. MATERIAL AND
METHOD: Seventy women with early breast cancer underwent the combined method of SLN detection during the period between September 2007 and December 2008. Standard criteria for each method were used to identify SLNs. Each SLN was labeled as identified by the blue dye, the radiocolloid and as being positive or negative for cancer cells.
RESULTS: Subjects were 50 years old with tumors of size 2.3 cm on the average. The average number of SLNs harvested was 2.5 nodes per subject. The detection rate for the isosulfan blue method was 91% (64/70). The relative false negative rate of the blue dye was zero (0/64).
CONCLUSION: Experienced surgeons who use the isosulfan blue method of SLN detection in early breast cancer can be reasonably confident that the false negative rate of the isosulfan blue method was similar to that of the combined method.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22435247

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis.

Authors:  Jiyu Li; Xiao Chen; Ming Qi; Yanshuang Li
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

2.  Comparison between sentinel lymph node hybrid scintigraphy and blue dye technique in breast cancer patients: An institutional experience.

Authors:  Maimoona Siddique; Aamna Hassan; Muhammad Khalid Nawaz; Humayun Bashir; Muhammad Zulqarnain Chaudhry
Journal:  World J Nucl Med       Date:  2020-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.